pulmoПульмонологияPULMONOLOGIYA0869-01892541-9617Scientific and Practical Journal “PULMONOLOGIYA” LLC10.18093/0869-0189-2011-0-3-101-107pulmo-338Research ArticleОБЗОРЫREVIEWФункциональные ответы альвеолярных макрофагов, сурфактантный белок D и заболевания легкихFunctions of alveolar macrophages and surfactant protein D in lung diseaseМалышевИ. Ю.MalyshevI. Yu.

д. м. н., проф., зав. лабораторией клеточных биотехнологий, зав. лабораторией стресса и адаптацией

127473, Москва, ул. Делегатская, 20 / 1

25315, Москва, ул. Балтийская, 8. Тел.: +7-985-766-24-40.

igor.malyshev@mtu-net.ruЛяминаС. В.LyaminaS. V.

к. м. н., старший научный сотрудник лаборатории клеточных биотехнологий

127473, Москва, ул. Делегатская, 20 / 1. Тел.: +7-915-018-50-06.

svlvs@mail.ruШимшелашвилиШ. Л.ShimshelashviliSh. L.

к. м. н., ассистент кафедры госпитальной терапевтической стоматологии, пародонтологии и гериатрической стоматологии 

127473, Москва, ул. Делегатская, 20 / 1. Тел.: +7-985-766-24-40.

igor.malyshev@mtu-net.ruВассерманЕ. Н.VassermanE. N.

к. м. н., старший научный сотрудник Школы медицины, отделения легочной и интенсивной терапии 

Vernon and Shirley Hill Pavilion, # H410C 380 S. University Ave. Philadelphia, PA 19104-4539. Тел.: +7-985-766-24-40.

igor.maly-shev@mtu-net.ruГОУ ВПО "Московский государственный медико-стоматологический университет Федерального агентства по здравоохранению и социальному развитию"; НИИ общей патологии и патофизиологии РАМНRussian FederationГОУ ВПО "Московский государственный медико-стоматологический университет Федерального агентства по здравоохранению и социальному развитию"Russian FederationПенсильванский университетUnited States20112806201103101107Copyright © Малышев И.Ю., Лямина С.В., Шимшелашвили Ш.Л., Вассерман Е.Н., 20112011Малышев И.Ю., Лямина С.В., Шимшелашвили Ш.Л., Вассерман Е.Н.Malyshev I.Y., Lyamina S.V., Shimshelashvili S.L., Vasserman E.N.Данная работа распространяется под лицензией Creative Commons Attribution 4.0.This work is licensed under a Creative Commons Attribution 4.0 License.https://journal.pulmonology.ru/pulm/article/view/338

Функциональные ответы альвеолярных макрофагов, сурфактантный белок D и заболевания легких.

Functions of alveolar macrophages and surfactant protein D in lung disease.

макрофагифенотипы макрофаговрепрограммированиесурфактантный белок Dзаболевания легкихmacrophagesmacrophage phenotypereprogrammingsurfactant protein Dlung diseaseReferencesЧучалин А.Г. (ред.). Стандарты по диагностике и лечению больных хронической обструктивной болезнью легких (ATS / ERS, пересмотр 2004 г.). Пер. с англ. М.: Атмосфера; 2005.Чучалин А.Г. (ред.). Стандарты по диагностике и лечению больных хронической обструктивной болезнью легких (ATS / ERS, пересмотр 2004 г.). Пер. с англ. М.: Атмосфера; 2005.Хаитов Р.М. Иммунология: Учебник. М.: ГЭОТАР-Медиа; 2006.Хаитов Р.М. Иммунология: Учебник. М.: ГЭОТАР-Медиа; 2006.Janeway C.A., Travers P., Walport M., Shlomchik M. Immunobiology. The immune system in health and disease: New York: Garland Science Publishing, 2005.Janeway C.A., Travers P., Walport M., Shlomchik M. Immunobiology. The immune system in health and disease: New York: Garland Science Publishing, 2005.Mantovani A., Sica A., Sozzani S. et al. The chemokine system in diverse forms of macrophage activation and polarization. Trends Immunol. 2004; 25: 677–686.Mantovani A., Sica A., Sozzani S. et al. The chemokine system in diverse forms of macrophage activation and polarization. Trends Immunol. 2004; 25: 677–686.Mantovani A. Macrophage diversity and polarization: in vivo veritas. Blood 2006; 108 (2): 408–409.Mantovani A. Macrophage diversity and polarization: in vivo veritas. Blood 2006; 108 (2): 408–409.Mantovani A., Sica A., Locatti A. New vistas on macrophage differentiation and activation. Eur. J. Immunol. 2006; 37 (1): 14–16.Mantovani A., Sica A., Locatti A. New vistas on macrophage differentiation and activation. Eur. J. Immunol. 2006; 37 (1): 14–16.Boehm U., Klamp T., Groot M., Howard J.C. Cellular responses to interferon-gamma. Ann. Rev. Immunol. 1997; 15: 749–795.Boehm U., Klamp T., Groot M., Howard J.C. Cellular responses to interferon-gamma. Ann. Rev. Immunol. 1997; 15: 749–795.Sharma M. Chemokines and their receptors: orchestrating a fine balance between health and disease. Crit. Rev. Biotechnol. 2010; 30: 1–22.Sharma M. Chemokines and their receptors: orchestrating a fine balance between health and disease. Crit. Rev. Biotechnol. 2010; 30: 1–22.Trost M., English L., Limieux S. et al. The phagosomal proteome in interferon-?-activated macrophages. Immunity 2009; 30 (1): 143–154.Trost M., English L., Limieux S. et al. The phagosomal proteome in interferon-?-activated macrophages. Immunity 2009; 30 (1): 143–154.Nelson S. Novel nonantibiotic therapies for pneumonia. Cytokines and host defence. Chest 2001; 119 (2): 419S–425S.Nelson S. Novel nonantibiotic therapies for pneumonia. Cytokines and host defence. Chest 2001; 119 (2): 419S–425S.Martinez F.O., Gordon S., Locati A., Mantovani A. Transcriptional profiling of the human monocyte-to-macrophage differentiation and polarization: New molecules and patterns of gene expression. J. Immunol. 2006; 177: 7303–7311.Martinez F.O., Gordon S., Locati A., Mantovani A. Transcriptional profiling of the human monocyte-to-macrophage differentiation and polarization: New molecules and patterns of gene expression. J. Immunol. 2006; 177: 7303–7311.Kaplan A.P. Chemokines, chemokine receptors and allergy. Int. Arch. Allergy Immunol. 2001; 124 (4): 423–431.Kaplan A.P. Chemokines, chemokine receptors and allergy. Int. Arch. Allergy Immunol. 2001; 124 (4): 423–431.Falcone F.H., Haas H., Gibbs B.F. The human basophil: a new appreciation of its role in immune responses. Blood 2000; 96 (13): 4028–4038.Falcone F.H., Haas H., Gibbs B.F. The human basophil: a new appreciation of its role in immune responses. Blood 2000; 96 (13): 4028–4038.D'Andrea A., Aste5Amezaga M., Valiante N.M. et al. Interleukin 10 (IL-10) inhibits human lymphocyte interferon gamma-production by suppressing natural killer cell stimulatory factor / IL-12 synthesis in accessory cells. J. Exp. Med. 1993; 178 (3): 1041–1048.D'Andrea A., Aste5Amezaga M., Valiante N.M. et al. Interleukin 10 (IL-10) inhibits human lymphocyte interferon gamma-production by suppressing natural killer cell stimulatory factor / IL-12 synthesis in accessory cells. J. Exp. Med. 1993; 178 (3): 1041–1048.Hu S., Sheng W.S., Peterson P.K., Chao C.C. Differential regulation by cytokines of production of nitric oxide by human astrocytes. Glia 1995; 15: 491–494.Hu S., Sheng W.S., Peterson P.K., Chao C.C. Differential regulation by cytokines of production of nitric oxide by human astrocytes. Glia 1995; 15: 491–494.Gordon S. The macrophage: Past, present and future. Eur. J. Immunol. 2007; 37: S9.Gordon S. The macrophage: Past, present and future. Eur. J. Immunol. 2007; 37: S9.Martinez F.O., Sica A., Mantovani A., Locati M. Macrophage activation and polarization. Front. Biosci. 2008; 1 (13): 453–461.Martinez F.O., Sica A., Mantovani A., Locati M. Macrophage activation and polarization. Front. Biosci. 2008; 1 (13): 453–461.Sieling P.A., Abrams J.S., Yamamura M. et al. Immunosuppressive roles for IL-10 and IL-4 in human infection. In vitro modulation of T cell responses in leprosy. J. Immunol. 1993; 150 (12): 5501–5510.Sieling P.A., Abrams J.S., Yamamura M. et al. Immunosuppressive roles for IL-10 and IL-4 in human infection. In vitro modulation of T cell responses in leprosy. J. Immunol. 1993; 150 (12): 5501–5510.Oosterhout A.J.M., Motta A.C. Th1 / Th2 paradigm: not seeing the forest for the trees? Eur. Respir. J. 2005; 25: 591–593.Oosterhout A.J.M., Motta A.C. Th1 / Th2 paradigm: not seeing the forest for the trees? Eur. Respir. J. 2005; 25: 591–593.Mantovani A., Sozzani S., Locati M. et al. Macrophage polarization: tumor-associated macrophages as a paradigm for polarized M2 mononuclear phagocytes. Trends Immunol. 2002; 23 (11): 549–555.Mantovani A., Sozzani S., Locati M. et al. Macrophage polarization: tumor-associated macrophages as a paradigm for polarized M2 mononuclear phagocytes. Trends Immunol. 2002; 23 (11): 549–555.Fritz J., Murphy B.S., Sundareshan V. et al. M1 and M2 Macrophage activation. Azithromycin alters macrophage phenotype. J. Antimicrob. Chemother. 2008; 61 (3): 554–560.Fritz J., Murphy B.S., Sundareshan V. et al. M1 and M2 Macrophage activation. Azithromycin alters macrophage phenotype. J. Antimicrob. Chemother. 2008; 61 (3): 554–560.Atochina E.N., Beck J.M., Scanlon S.T. et al. Pneumocystis carinii pneumonia alters expression and distribution of lung collectins SP-A and SP-D. J. Lab. Clin. Med. 2001; 137: 429–39.Atochina E.N., Beck J.M., Scanlon S.T. et al. Pneumocystis carinii pneumonia alters expression and distribution of lung collectins SP-A and SP-D. J. Lab. Clin. Med. 2001; 137: 429–39.Atochina E.N., Beers M.F., Hawgood S. et al. Surfactant protein-D, a mediator of innate lung immunity, alters the products of nitric oxide metabolism. Am. J. Respir. Cell Mol. Biol. 2004; 30: 271–279.Atochina E.N., Beers M.F., Hawgood S. et al. Surfactant protein-D, a mediator of innate lung immunity, alters the products of nitric oxide metabolism. Am. J. Respir. Cell Mol. Biol. 2004; 30: 271–279.Cheng G., Ueda T., Numao T. et al. Increased levels of surfactant protein A and D in bronchoalveolar lavage fluids in patients with bronchial asthma. Eur. Respir. J. 2000; 16: 831–835.Cheng G., Ueda T., Numao T. et al. Increased levels of surfactant protein A and D in bronchoalveolar lavage fluids in patients with bronchial asthma. Eur. Respir. J. 2000; 16: 831–835.Cheng I.W., Ware L.B., Greene K.E. et al. Prognostic value of surfactant proteins A and D in patients with acute lung injury. Crit. Care Med. 2003; 31: 20–27.Cheng I.W., Ware L.B., Greene K.E. et al. Prognostic value of surfactant proteins A and D in patients with acute lung injury. Crit. Care Med. 2003; 31: 20–27.Eisner M.D., Parsons P., Matthay M.A. et al. Plasma surfactant protein levels and clinical outcomes in patients with acute lung injury. Thorax 2003; 58: 983–988.Eisner M.D., Parsons P., Matthay M.A. et al. Plasma surfactant protein levels and clinical outcomes in patients with acute lung injury. Thorax 2003; 58: 983–988.Fujita M., Shannon J.M., Ouchi H. et al. Serum surfactant protein D is increased in acute and chronic inflammation in mice. Cytokine 2005; 31: 25–33.Fujita M., Shannon J.M., Ouchi H. et al. Serum surfactant protein D is increased in acute and chronic inflammation in mice. Cytokine 2005; 31: 25–33.Kuan S., Rust K., Crouch E. Interactions of surfactant protein D with bacterial lipopolysaccharides. J. Clin. Invest. 1992; 90: 97–106.Kuan S., Rust K., Crouch E. Interactions of surfactant protein D with bacterial lipopolysaccharides. J. Clin. Invest. 1992; 90: 97–106.Wright J.R. Immunomodulatory functions of surfactant. Physiol. Rev. 1997; 77: 931–962.Wright J.R. Immunomodulatory functions of surfactant. Physiol. Rev. 1997; 77: 931–962.Crouch E.C. Structure, biologic properties and expression of surfactant protein D. Biochim. Biophys. Acta 1998; 1408: 278–289.Crouch E.C. Structure, biologic properties and expression of surfactant protein D. Biochim. Biophys. Acta 1998; 1408: 278–289.Sorensen G.L., Husby S., Holmskov U. Surfactant protein A and surfactant protein D variation in pulmonary disease. Immunobiology 2007; 212 (4–5): 381–416.Sorensen G.L., Husby S., Holmskov U. Surfactant protein A and surfactant protein D variation in pulmonary disease. Immunobiology 2007; 212 (4–5): 381–416.Sin D.D., Pahlavan P.S., Man P.S.P. Surfactant protein D: A lung specific biomarker in COPD?: Potential biological roles of SP-D in COPD. Ther. Adv. Respir Dis. 2008; 2 (2): 65–74.Sin D.D., Pahlavan P.S., Man P.S.P. Surfactant protein D: A lung specific biomarker in COPD?: Potential biological roles of SP-D in COPD. Ther. Adv. Respir Dis. 2008; 2 (2): 65–74.Fisher J.H., Larson J., Cool C., Dow S.W. Lymphocyte activation in the lungs of SP-D null mice. Am. J. Respir. Cell. Mol. Biol. 2002; 27: 24–33.Fisher J.H., Larson J., Cool C., Dow S.W. Lymphocyte activation in the lungs of SP-D null mice. Am. J. Respir. Cell. Mol. Biol. 2002; 27: 24–33.Botas C.F., Poulain J., Akiyama J. et al. Altered surfactant homeostasis and alveolar type II cell morphology in mice lacking surfactant protein D. Proc. Natl. Acad. Sci. USA 1998; 95:11869–11874.Botas C.F., Poulain J., Akiyama J. et al. Altered surfactant homeostasis and alveolar type II cell morphology in mice lacking surfactant protein D. Proc. Natl. Acad. Sci. USA 1998; 95:11869–11874.Wert S.E., Yoshida M., LeVine A.M. et al. Increased metalloproteinase activity, oxidant production, and emphysema in surfactant protein D gene-inactivated mice. Proc. Natl. Acad. Sci. USA 1997; 97: 5972–5977.Wert S.E., Yoshida M., LeVine A.M. et al. Increased metalloproteinase activity, oxidant production, and emphysema in surfactant protein D gene-inactivated mice. Proc. Natl. Acad. Sci. USA 1997; 97: 5972–5977.Korfhagen T.R., Sheftelyevich V., Burhans M.S. et al. Surfactant protein-D regulates surfactant phospholipid homeostasis in vivo. J. Biol. Chem. 1998; 273: 28438–28443.Korfhagen T.R., Sheftelyevich V., Burhans M.S. et al. Surfactant protein-D regulates surfactant phospholipid homeostasis in vivo. J. Biol. Chem. 1998; 273: 28438–28443.Yoshida M., Korfhagen Th.R., Whitsett J.A. Surfactant protein D regulates NF-κB and matrix metalloproteinase production in alveolar macrophages via oxidant-sensitive pathways. J. Immunol. 2001; 166: 7514–7519.Yoshida M., Korfhagen Th.R., Whitsett J.A. Surfactant protein D regulates NF-κB and matrix metalloproteinase production in alveolar macrophages via oxidant-sensitive pathways. J. Immunol. 2001; 166: 7514–7519.LeVine A.M., Whitsett J.A., Gwozdz J.A. et al. Distinct effects of surfactant protein A or D deficiency during bacterial infection on the lung. J. Immunol. 2000; 165: 3934–3940.LeVine A.M., Whitsett J.A., Gwozdz J.A. et al. Distinct effects of surfactant protein A or D deficiency during bacterial infection on the lung. J. Immunol. 2000; 165: 3934–3940.Gardai S.J., Xiao Y.5Q., Dickinson M. et al. By binding SIRP-alpha or calreticulin / CD91, lung collectins act as dual function surveillance molecules to suppress or enhance inflammation. Cell 2003; 115: 13–23.Gardai S.J., Xiao Y.5Q., Dickinson M. et al. By binding SIRP-alpha or calreticulin / CD91, lung collectins act as dual function surveillance molecules to suppress or enhance inflammation. Cell 2003; 115: 13–23.Atochina5Vasserman E.N., Kadire H., Tomer Y. et al. Selective inhibition of iNOS activity in vivo reverses inflammatory abnormalities in SP-D deficient mice. J. Immunol. 2007; 179 (12): 8090–8097.Atochina5Vasserman E.N., Kadire H., Tomer Y. et al. Selective inhibition of iNOS activity in vivo reverses inflammatory abnormalities in SP-D deficient mice. J. Immunol. 2007; 179 (12): 8090–8097.Atochina5Vasserman E.N., Abramova E.V., Tomer Y. et al. SP-D-Dependent regulation of NO metabolism in lipopolysaccharide-stimulated peritoneal macrophages. Bull. Exp. Biol. Med. 2009; 147 (4): 415–420.Atochina5Vasserman E.N., Abramova E.V., Tomer Y. et al. SP-D-Dependent regulation of NO metabolism in lipopolysaccharide-stimulated peritoneal macrophages. Bull. Exp. Biol. Med. 2009; 147 (4): 415–420.Sano H., Kuroki Y. The lung collectins, SP-A and SP-D, modulate pulmonary innate immunity. Mol. Immunol. 2005; 42 (3): 279–287.Sano H., Kuroki Y. The lung collectins, SP-A and SP-D, modulate pulmonary innate immunity. Mol. Immunol. 2005; 42 (3): 279–287.Guo C.J., Atochina5Vasserman E.N., Abramova H. et al. S-Nitrosylation of surfactant protein-D controls inflammatory function. PLoS Biol. 2008; 6 (11): e266.Guo C.J., Atochina5Vasserman E.N., Abramova H. et al. S-Nitrosylation of surfactant protein-D controls inflammatory function. PLoS Biol. 2008; 6 (11): e266.Zhang L., Ikegami M., Crouch E.C. et al. Activity of pulmonary surfactant protein-D (SP-D) in vivo is dependent on oligomeric structure. J. Biol. Chem. 2001; 276 (22): 19214–19219.Zhang L., Ikegami M., Crouch E.C. et al. Activity of pulmonary surfactant protein-D (SP-D) in vivo is dependent on oligomeric structure. J. Biol. Chem. 2001; 276 (22): 19214–19219.Guo C.J., Rashman C.S., Wolf B.A., Gow A.J. S-Nitrosylation of surfactant protein-D provides a molecular switch from anti- to pro-inflammatory function. Nitric Oxide 2006; 14 (4): 6.Guo C.J., Rashman C.S., Wolf B.A., Gow A.J. S-Nitrosylation of surfactant protein-D provides a molecular switch from anti- to pro-inflammatory function. Nitric Oxide 2006; 14 (4): 6.McCormack F.X., Whitsett J.A. The pulmonary collectins, SP-A and SP-D, orchestrate innate immunity in the lung. J. Clin. Invest 2002; 109 (6): 707–712.McCormack F.X., Whitsett J.A. The pulmonary collectins, SP-A and SP-D, orchestrate innate immunity in the lung. J. Clin. Invest 2002; 109 (6): 707–712.Bartlett J.G., Breiman R.F., Mandell L.A. et al. Communityacquired pneumonia in adults-guidelines for management. Clin. Infect. Dis. 1998; 26: 811–838.Bartlett J.G., Breiman R.F., Mandell L.A. et al. Communityacquired pneumonia in adults-guidelines for management. Clin. Infect. Dis. 1998; 26: 811–838.Bufler P., Schikor D., Schmidt B., Griese M. Cytokine stimulation by Pseudomonas aeruginosa strain variation and modulation by pulmonary surfactant. Exp. Lung Res. 2004; 30 (3): 163–179.Bufler P., Schikor D., Schmidt B., Griese M. Cytokine stimulation by Pseudomonas aeruginosa strain variation and modulation by pulmonary surfactant. Exp. Lung Res. 2004; 30 (3): 163–179.Lofdahl M., Wahlstorm J., Skold C.M. Different inflammatory cell pattern and macrophage phenotype in chronic obstructive pulmonary disease patients, smokers and non-smokers. Clin. Exp. Immunol. 2006; 145 (3): 428–437.Lofdahl M., Wahlstorm J., Skold C.M. Different inflammatory cell pattern and macrophage phenotype in chronic obstructive pulmonary disease patients, smokers and non-smokers. Clin. Exp. Immunol. 2006; 145 (3): 428–437.Pons A.R., Noguera A., Blanquer D. et al. Phenotypic characterization of alveolar macrophages and peripheral blood monocytes in COPD. Eur. Respir. J. 2005; 25 (4): 647–652.Pons A.R., Noguera A., Blanquer D. et al. Phenotypic characterization of alveolar macrophages and peripheral blood monocytes in COPD. Eur. Respir. J. 2005; 25 (4): 647–652.Shaykhiev R., Krause A., Salit J. et al. Smoking-dependent reprogramming of alveolar macrophage polarization: implication for pathogenesis of chronic obstructive pulmonary disease. J. Immunol. 2009; 183: 2867–2883.Shaykhiev R., Krause A., Salit J. et al. Smoking-dependent reprogramming of alveolar macrophage polarization: implication for pathogenesis of chronic obstructive pulmonary disease. J. Immunol. 2009; 183: 2867–2883.Лещенко И.В. Глобальная инициатива по хронической обструктивной болезни легких: новые направления в лечении. Урал. мед. Журн. 2006; 8 (36).Лещенко И.В. Глобальная инициатива по хронической обструктивной болезни легких: новые направления в лечении. Урал. мед. Журн. 2006; 8 (36).Sethi S., Maloney J., Grove L. et al. Airway inflammation and bronchial bacterial colonization in chronic obstructive pulmonary disease. Res. Med. COPD Update 2006; 1 (4): 144–145.Sethi S., Maloney J., Grove L. et al. Airway inflammation and bronchial bacterial colonization in chronic obstructive pulmonary disease. Res. Med. COPD Update 2006; 1 (4): 144–145.Доклад экспертов ВОЗ; 2005.Доклад экспертов ВОЗ; 2005.Woodruff P.G., Modrek B., Choy D.F. et al. T-helper type 2-driven inflammation defines major subphenotypes of asthma. Am. J. Respir. Crit. Care Med. 2009; 180 (5): 388–395.Woodruff P.G., Modrek B., Choy D.F. et al. T-helper type 2-driven inflammation defines major subphenotypes of asthma. Am. J. Respir. Crit. Care Med. 2009; 180 (5): 388–395.Шмелев Е.И. Дифференциальная диагностика интерстициальных заболеваний легких. Consilium Medicum 2003; 5 (4): 176–181.Шмелев Е.И. Дифференциальная диагностика интерстициальных заболеваний легких. Consilium Medicum 2003; 5 (4): 176–181.Kunitake R., Kuwano K., Yoshida K. et al. KL-6, surfactant protein A and D in bronchoalveolar lavage fluid from patients with pulmonary sarcoidosis. Respiration 2001; 68: 488–495.Kunitake R., Kuwano K., Yoshida K. et al. KL-6, surfactant protein A and D in bronchoalveolar lavage fluid from patients with pulmonary sarcoidosis. Respiration 2001; 68: 488–495.Kucejko W., Chyczewska E., Naumnik W., Ossolinska M. Concentration of surfactant protein D, Clara cell protein CC-16 and IL-10 in bronchoalveolar lavage (BAL) in patients with sarcoidosis, hypersensivity pneumonitis and idiopathic pulmonary fibrosis. Folia Histochem. Cytobiol. 2009; 47 (2): 225–230.Kucejko W., Chyczewska E., Naumnik W., Ossolinska M. Concentration of surfactant protein D, Clara cell protein CC-16 and IL-10 in bronchoalveolar lavage (BAL) in patients with sarcoidosis, hypersensivity pneumonitis and idiopathic pulmonary fibrosis. Folia Histochem. Cytobiol. 2009; 47 (2): 225–230.Zissel G., Prasse A., Muller5Quernheim J. Sarcoidosisimmunopathogenetic concepts. J. Semin. Respir. Crit. Care Med. 2007; 28 (1): 3–14.Zissel G., Prasse A., Muller5Quernheim J. Sarcoidosisimmunopathogenetic concepts. J. Semin. Respir. Crit. Care Med. 2007; 28 (1): 3–14.Prasse A., Georges C.G., Biller H. et al. Тh1 cytokine pattern in sarcoidosis is expressed by bronchoalveolar CD4+ and CD8+ T cells. Clin. Exp. Immunol. 2000; 122 (2): 241–248.Prasse A., Georges C.G., Biller H. et al. Тh1 cytokine pattern in sarcoidosis is expressed by bronchoalveolar CD4+ and CD8+ T cells. Clin. Exp. Immunol. 2000; 122 (2): 241–248.

The authors declare that there are no conflicts of interest present.